Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Synose Tech is a specialized biotechnology company and CDMO focused on the development and large-scale manufacture of high-quality nucleosides, nucleotides, and phosphoramidites. The company is recognized as a premier global supplier of critical raw materials for mRNA vaccines, most notably N1-Methylpseudouridine. Their expertise encompasses the synthesis of modified nucleosides and reagents essential for the production of DNA and RNA-based therapeutics, including antisense oligonucleotides and siRNA. Operating out of state-of-the-art facilities in Hangzhou and Quzhou, Synose Tech provides comprehensive services from R&D to commercial-scale production. The company serves a diverse international client base in the pharmaceutical and biotechnology sectors, adhering to stringent quality standards. Synose Tech's capabilities support the entire lifecycle of nucleic acid drug development, from early-stage research to global commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Synose Tech.